Use of ΔIVC for Early Diagnosis of AHF in AECOPD
Diagnosis of Acute Heart Failure in Chronic Obstructive Pulmonary Disease Exacerbation Using the Inferior Vena Cava Collapsibilty Index
1 other identifier
observational
401
1 country
3
Brief Summary
Acute Heart failure (AHF) is a common cause of acute exacerbation of chronic obstructive pulmonary disease (AECOPD). This association is frequently underestimated with regard to the difficulty of clinical diagnosis. The investigators expect that the application of the inferior vena cava collapsibility index (ΔIVC)could be useful in this issue.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Mar 2022
Shorter than P25 for all trials
3 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2022
CompletedFirst Submitted
Initial submission to the registry
March 14, 2022
CompletedFirst Posted
Study publicly available on registry
April 14, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 30, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
January 31, 2023
CompletedMay 16, 2023
May 1, 2023
9 months
March 14, 2022
May 13, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
the performance of ΔIVC in the diagnosis of acute heart failure
the accuracy of ΔIVC in the diagnosis of heart failure measured by sensitivity ,specificity, and area under the roc curve
1 day
Study Arms (2)
AHF-group
patients with AECOPD and acute heart failure
non AHF-group
patients with AECOPD without acute heart failure
Interventions
the ΔIVC was calculated by the emergency physician who was blinded from the patient's medical history using the formula ((IVCmax-IVCmin)/IVCmax) X100.A cutoff of 15% was used to define the presence(\<15%) or absence(\>15%) of heart failure
Eligibility Criteria
patients with history of COPD admitted to the emergency departmet for AECOPD and stable hemodynamic status
You may qualify if:
- patient with history of COPD and admitted to the emergency departement for AECOPD
You may not qualify if:
- impossibility to give consent to participate in the study, non consent patients
- post traumatic dyspnea
- instable hemodynamic or neurological status
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (3)
CHU Fattouma Bourguiba
Monastir, 5000, Tunisia
Emergency Departement
Monastir, 5000, Tunisia
Emergency department of fattouma bourguiba university hospital
Monastir, 5020, Tunisia
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Nouira Semir, Professor
University of Monastir
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- professor
Study Record Dates
First Submitted
March 14, 2022
First Posted
April 14, 2022
Study Start
March 1, 2022
Primary Completion
November 30, 2022
Study Completion
January 31, 2023
Last Updated
May 16, 2023
Record last verified: 2023-05